Opening Ceremony & Keynote Plenary

• Opening Ceremony

• CPIC Award

• Global Biomedical Technology Frontiers

• Dialogue with Leaders of China’s Innovative Pharma Companies

• MNC Executive Keynotes

• Major Clinical Data Announcements

• The Global Race and China’s Strength

• AI Transforming Pharma Innovation

• Cross-Industry Insights in Pharma

Registration Regulations and Drug Regulation

• Global Novel Drug Review & Approval and Registration Compliance

• Drug Market Access in Emerging Markets

• China’s IIT Regulatory Model

• Biosimilar Registration and Regulatory Requirements

• Nonclinical Evaluation of Novel Drugs

• Human-Machine Collaborative Intelligent Review and Approval System

• CMC & GMP Compliance and Inspections for Novel Drug

Frontier Biotechnology Track

• Antibody Therapeutics Innovation and Development

• ADC Innovation and Development

• Small Nucleic Acid Drugs Innovation

• Cancer Vaccine Innovation

• In Vivo CAR-T Innovation

• Stem Cell Therapy Innovation

• Immune Cell Therapy Innovation

• The Future Path of AAV Innovation

• Radiopharmaceutical Innovation and Development

• GLP-1/Peptide Therapeutics Innovation

• Small Molecule Drug Innovation

• Complex Drug Products Development

• Molecular Glue and PROTAC

• Novel Drug Delivery Systems

• Exosome Technology Development and Applications

• Live Biotherapeutic Product Development

• Organoids and Organs-on-chips

• Drug-Device Combination Products Development

• Translational Medicine and Companion Diagnostics

• Brain-Computer Interface

• Embodied AI Robotics

AI for Science (AI4S) and AI Drug Discovery

• New Paradigms for Novel Drug R&D in the AI Era

• A New Era of Pharma Driven by Digital Intelligence

• AI-Driven Drug Discovery and Optimization

• AI-Driven Bioprocess Innovation

• AI Reshaping the End-to-End Clinical Development Chain

• AI-Driven Innovation Practices in Pharma

• AI Healthcare

Innovative Development in High-Interest Therapeutic Areas

• Oncology and Autoimmune Drug Development

• Novel Drug R&D for Metabolic Disorders

• CNS Novel Drug R&D Session

• Ophthalmology Drug Development

• Clinical Development and Commercialization of Rare Disease Therapies

• Specialty Drug Innovation and Development Session

Manufacturing and Supply Chain

• Commercial Manufacturing and CMC

• Bioprocess Engineering and Global Industrialization

• Cryogenic Bioprocessing

• Novel Drug Delivery Technologies

• Digital Factory and intelligent Manufacturing

• Pharmaceutical Cold Chain Logistics and Radiopharmaceutical Logistics Management

BD and Global Market Partnerships

• Embracing a New Era of Pharma BD

• Global BD Partnerships for Novel Drugs

• Deal-Making Power for Novel Drugs

• Cross-Border M&A

• Synergistic Development of Local Commercialization and Global Markets

• Cross-Border Financing and Innovative Capitalization Pathways for Novel Drugs

• China-U.S. Biomedical Collaboration

• China-Europe Biomedical Collaboration

• China-Japan Biomedical Collaboration

• BRICS+ Biomedical Collaboration

• China-Korea Biomedical Collaboration

• Southeast Asia Biomedical Collaboration

• Hong Kong, Macao, and Taiwan Biomedical Collaboration

Capitalization and Commercialization of Novel Drugs

• China Healthcare Investment and M&A

• Capital Strategy for Biopharma Companies

• CFO Forum

• Hong Kong IPO and Listing for Biopharma Companies

• The Evolution and Beyond of NewCo

• Cross-Border Investment Session

• Diversified Payment Models for Novel Drugs

• Market Access for Novel Drugs

Clinical Development and Real‑World Evidence

• Early-Phase Clinical Trials for Novel Drugs

• Practical Biostatistics for Novel Drug Development

• Data Management

• Clinical Operations

• Adaptive Clinical Trials

• Real-World Data Applications and Innovation

• Pharmacovigilance

• CTD/eCTD Electronic Submissions and Process Reengineering

• Medical Affairs

Building the Novel Drug Ecosystem

• Intellectual Property Protection

• Innovation and Transformation of Traditional Pharma Companies

• Biomedical Park Development

• ESG Development in Biopharma

• Human Resources Development for Biopharma Companies

• PR and IR for Biopharma Companies

Roadshows and Announcements

• CPIC Roadshow

• Clinical Data Announcements

• Major Product/Platform Launches

• Blue Book Release

• Key Signing Ceremony

Corporate Satellite Meetings

• Companies as Host Organizations; Topics and Content Curated by the Companies

One-on-One Meetings

• New One-on-One Meeting System Under Development